Angiogenesis is regarded as essential for tumour growth. However, we have demonstrated that some other aggressive non-small-cell lung carcinomas (n-SCLC) do not have angiogenesis. In this study, using cDNA microarray analysis, we demonstrate that angiogenic and nonangiogenic tumour types can be distinguished by their gene expression profiles. Tissue samples from 42 n-SCLC patients were obtained with consent. In all, 12 tumours were nonangiogenic and 30 angiogenic. The two groups were matched by age, sex, smoking and tumour stage. Total RNAs were extracted followed by microarray hybridization and image scan procedure. Data were analysed using GeneSpring 5.1 software. A total of 62 genes were found to be able to separate angiogenic from nonangiogenic tumours. Nonangiogenic tumours have higher levels of genes concerned with mitochondrial metabolism, mRNA transcription, protein synthesis and the cell cycle. Angiogenic tumours have higher levels of genes coding for membrane vesicles, integrins, remodelling, angiogenesis and apoptosis. These results further support our first finding that nonangiogenic lung tumours are fast-growing tumours filling the alveoli in the absence of vascular remodelling. We raise the hypothesis that in nonangiogenic tumours, hypoxia leads to a higher activation of the mitochondrial respiratory chain, which allows tumour growth without triggering angiogenesis.
Introduction
In 1971, Folkman first established the hypothesis that tumour growth is dependent on angiogenesis, that is, the growth of new vessels from pre-existing ones. In fact, the nature and the role played by vessels in tumour growth have been debated for the last 50 years. Extensive studies have demonstrated that angiogenesis is essential for the growth of solid tumours and that 'yany tumour that is large enough to be visible or palpable has already undergone neovascularization to attain that size' (Kerbel and Folkman, 2002) . However, we and others (Holash et al., 1999; Van Coillie et al., 2001) have reported that clinically detectable tumours grow without evidence of neoangiogenesis by co-opting pre-existing vessels.
In particular, we have reported that some non-small-cell lung cancers (n-SCLCs) and lung metastases can exploit pre-existing vessels and grow, without angiogenesis, by filling the alveolar spaces (Pezzella et al., 1996 (Pezzella et al., , 2000 . Further investigation of these nonangiogenic tumours has shown that the vascular phenotype is the same as that of normal alveolar vessels (Passalidou et al., 2002) .
cDNA microarray analysis is a powerful tool with which to profile gene expression in tumours. Two different approaches have been described previously, class discovery, by unsupervised clustering, and class comparison, by supervised analysis (Miller et al., 2002) . The present study of n-SCLC from patients diagnosed with stage I disease was undertaken to identify by class comparison analysis whether differences in gene expression occur between angiogenic and nonangiogenic tumours.
Results

cDNA microarray findings
A group of 62 genes was found to be able to separate clearly the angiogenic from the nonangiogenic tumours ( Figure 1 ): 22 genes were expressed more in angiogenic and 40 higher in nonangiogenic tumours. A complete list of these genes, the pathways to which they belong and their subcellular locations are described in the Supplementary data. Selected genes and pathways are shown in Table 1 .
Nonangiogenic tumours had higher levels of genes concerned with mitochondrial metabolism, mRNA Figure 1 Identification of genes that can differentiate between angiogenic and nonangiogenic (labelled as na) tumours. Data are presented in a matrix format: each row represents a gene on the microarray and each column an individual mRNA sample. The results presented represent the ratio of hybridization of fluorescent cDNA probes prepared from each experimental mRNA sample to a reference mRNA sample. These ratios are a measure of relative gene expression in each experimental sample and were depicted according to the colour scale shown at the bottom. Grey indicates missing data or excluded data transcription, protein synthesis pathways and cell cycle activity. Angiogenic tumours had higher levels of genes relating to membrane vesicles, angiogenesis, tissue remodelling pathways and apoptosis. Finally, three out of these 62 genes have unknown functions (Supplementary section 5).
We also wanted to look for correlations between genes: to do so, we employed a 'relevance network', a statistical technique based on a regression test, designed to generate the 'hypotheses of putative functional relationship between pairs of genes' (Butte et al., 2000) . Correlation constructions were built up from the 62 genes in the 42 patients of the angio vs nonangio groups. We compared the relationship between genes and between genes and angiogenic status. By pairwise comparison, we identified 1922 pairs of genes or pairs made up of a gene and angiogenic status. Roughly 483 of these pairs had a significant correlated relationship.
Further stepwise regressions based on those 483 significant pairs were carried out and a number of putative links between genes or a gene and the angiogenic status were discovered (see Supplementary data). Further stepwise regressions based on those 483 significant correlations were carried out: 12 genes had a number of pairings with other genes and, some, with angiogenic status (see Supplementary data).
Mitotic count
In the angiogenic tumours, there was an average of 0.5% of cells in mitosis, whereas in the nonangiogenic tumours, the average number of mitotic cells was double: 1.2%. By the unpaired t-test, the difference was significant (P ¼ 0.0013).
Real-time quantitative RT-PCR validates the expression of four genes
Four genes were selected for study by TaqMan quantitative RT-PCR. These were ANXA7 and SOD1 (higher in nonangiogenic tumours) and SEMAE and ARHE (higher in angiogenic tumours). The gene expression patterns shown by RT-PCR were similar to those found by microarray analysis (Figure 2 ).
Immunostaining for SOD1 and Thrombospondin 1
The results are shown in Figure 3 . In line with the mRNA results, Thrombospondin 1 is expressed in a larger area of stroma in angiogenic tumours than in nonangiogenic tumours (unpaired t-test, P ¼ 0.0011), while SOD1 is expressed in a higher number of cells with higher intensity in nonangiogenic tumours (however, unpaired t-test, P ¼ 0.28).
Control replicas by paired t-test
Assessment of experimental variance showed that the difference of measurements fell within 95% confidence intervals of 0.49-0.88 with a mean of 0.68 (P>0.05), indicating that the hybridization experiments, when repeated, provided comparable results.
Discussion
The present study demonstrates that angiogenic and nonangiogenic n-SCLCs can be clustered apart by the differential expression of a consistent number of genes. Furthermore, it highlights differences in the activation of a number of pathways related to the angiogenic switch.
One of the most interesting findings was the presence in nonangiogenic tumours of higher levels of genes coding for proteins involved in mitochondrial metabolism. This finding suggests a more effective regulation of the intracellular respiratory chain in these tumours. Genes of particular interest in this group are the NADH dehydrogenase 1beta 17 kDa (NDUFB6) and protease serine 15 (PRSS15). NDFUB6 belongs to the first enzyme complex of the mitochondrial respiratory chain and has been found to be highly expressed in normal tissues with a high energy demand, such as kidney and heart (Smeitink et al., 1998) . PRSS15 is a multifunctional protein widely preserved throughout species from yeast to mammals (Lu et al., 2003) . Its expression, in a rat model and in the human HeLa cell line, has been found to be induced by hypoxia (Hori et al., 2002) . HeLa cells transfected with PRSS15 were relatively more resistant to the decrease in mitochondrial membrane potential induced by hypoxia than the mocktransfected cells (Hori et al., 2002) . Human PRSS15 binds to TG-rich elements, where it is presented in the context of a single DNA strand. These findings suggest that human PRSS15 might regulate mitochondrial DNA replication and/or gene expression using site-specific, single-stranded DNA binding to target the degradation of regulatory proteins binding to adjacent sites in mitochondrial promoters (Fu and Markovitz, 1998) . Our hypothesis that PRSS15 could be a crucial gene in dictating the growth of nonangiogenic tumours is further supported by our finding (manuscript in preparation) that PRSS15 gene is highly transcribed in hypertrophic myocardium from patients with aortic stenosis.
We have found that nonangiogenic tumours expressed a panel of hypoxia-related proteins in manner We therefore hypothesize that hypoxia induces an increase in mitochondrial function in nonangiogenic tumors that compensates for the diminished oxygenation and allows neoplastic growth without triggering angiogenesis. Two other pathways that are more active in nonangiogenic tumours are those involving transcription and, in particular, those involving RNA polymerase II and those associated with cell cycle regulation. A major expression of genes involved in the cell cycle is reflected by the higher mitotic count found in these tumours.
In angiogenic tumours, there were higher levels of expression of genes coding for membrane vesicles, angiogenesis and remodelling and inflammation-related pathways. Among the genes regulating vesicles, a finding of particular interest is the higher level of Clathrin. Clathrin-coated pits serve as a concentration device for internalizing macromolecules such as growth factor receptors. This process of receptor-mediated endocytosis increases the efficiency of ligand internalization. By this mechanism, angiogenic tumours may be rendered more sensitive to the specific ligands that induce angiogenesis.
Integrins are important both in neoangiogenesis and cell adhesion, two functions expected to be more developed in angiogenic tumours. Among our angiogenic cases, there was a higher level of Integrin Beta 4 that is involved in cell-to-cell adhesion, in cell-tomembrane adhesion and in inducing VEGF activation. In addition, there was a higher level of phosphoinositide 3 kinase (PI3K), an enzyme on the ITG beta pathways that is essential to Integrin B4 function. PI3K is of particular interest in this context because it is upregulated by hypoxia and is involved in HIF-1 activation (Harris, 2002) . It has also been recently reported that the PI3K inhibitor LY294002 has a significant antitumour property 'in vivo' (Su et al., 2003) .
Furthermore, the collagen type VII gene was upregulated in angiogenic tumours. This gene is involved in the adhesion of epithelial cells to basement membranes, and mutations both of this gene and of ITGB4 are known to result in the blistering disease Epidermolysis bullosa (Gil et al., 1994) . These findings strongly suggest that both genes co-operate to influence cell adhesion in angiogenic tumours. A further indication of a difference in angiogenic activity was the finding that thrombospondin mRNA is higher in angiogenic tumours. This protein is an inhibitor of angiogenesis (Jimenez et al., 2000) , which acts during the remodelling process in neoangiogenesis without harming the pre-existing vasculature (Volpert et al., 2002) .
This study also found a differential expression of six genes involved in the regulation of apoptosis. The pattern of expression found (Table 1) suggests that more apoptosis occurs in angiogenic tumours.
Finally, we tried to elucidate the functional network relationship of genes with the angiogenic status by using the regression and stepwise regression test. Out of the 12 genes we found paired with others, two were of particular interest to us. PRSS15, the mitochondrial gene we discussed above, was found associated with the following seven genes: TAFIBETA, TSP1, CGI07, ITM2A, POLR2K, NDUFB6 and ATP5O. However, PRSS15 was independent of angiogenic status. The second gene of interest to us was ITGB4: this gene has been discovered to be able to induce transcription of VEGF, a very well-known angiogenic factor, in breast cancer cells (Chung et al., 2002) . ITGB4 is not only highly associated with (R-seq ¼ 65%) the following four genes: CLTA, SEMAE, KIAA0476 and ANXA7, but also dependent on the angiogenic status. We thus generated our hypotheses that also in lung cancer, ITGB4 could be responsible for induction of VEGF transcription, while PRSS15 is the consequence of angiogenesis.
In conclusion, microarray analysis supports our initial hypothesis Pezzella et al., 1997) that nonangiogenic tumours are a separate group of fast-growing malignancies without evidence of vascular remodelling. Furthermore, this shows that they could have little apoptosis and a very efficient mitochondrial metabolism.
Materials and methods
Patients and tissue samples
Primary n-SCLC tissues were obtained with informed consent from 42 patients with smoking history who underwent radical surgical resection in Rome (Department of Thoracic Surgery, Catholic University) during 1998-2001 (see Supplementary data Table 1 : microarray experimental samples and clinical information). This research project was approved by the local ethical committee. In all, 12 tumours were classified as nonangiogenic and 30 as angiogenic n-SCLCs, as described previously . In both groups, a comparable percentage of adenocarcinomas and squamous cell carcinomas was present (see Supplementary data Table 1 ). Also, both groups were matched by age, sex, smoking and tumour stage.
Tissues were snap frozen in liquid nitrogen and then stored at À801C. For all cases the diagnosis was established on routine formalin-fixed paraffin-embedded material. Sections were obtained from each frozen sample before mRNA extraction. One section was stained with haematoxylin and eosin to verify the presence of viable tumour; another was immunostained for CD34 to assess the vascular pattern as described previously.
RNA extraction and reference pool preparation
Detailed protocols can be viewed in the Supplementary data. Briefly, tissue samples were homogenized in Trizol reagent (Gibco BRL) and total RNA was isolated by Trizol reagent, following standard procedures (Invitrogen). Total RNA quality was checked by 1% agarose gel in RNA loading buffer (95% Formamide, 18 mM EDTA, 0.025% SDS, 0.025% Bromophenol blue). Poly A selection was then performed by QIAGEN oligotex kit. A pool of mRNA from 10 neoplastic cell lines was used as reference for the cDNA microarray hybridizations (see Supplementary data). This reference provided an internal standard when compared against each experimental sample.
Microarray procedures
The microarrays used in this study were human cDNA microarrays, from the Sanger Centre (Hixton, Cambridge, UK) as part of the LICR/CRUK Microarray Consortium, and manufactured by depositing PCR products of cDNA clones onto 3D-Link-activated glass slides. Each array contains 10 750 spots representing 9932 sequence-validated cDNA elements for 6000 known, named human genes/ESTs. Information regarding the clone set and array preparation can be obtained from http://www.sanger.ac.uk/Projects/Microarrays. The technology platform for printing and processing slides can be viewed at http://www.biorobotics.com.
In all, 25 mg of total RNA or 1 mg of messenger RNA was annealed to oligo (dT) and reverse transcribed in the presence of Cy3 or Cy5-labelled dCTP by CyScribe first-strand cDNA labelling kit (Amersham, UK). In our experiments, we labelled cDNA from tissue samples with Cy3 (experimental channel) and cDNA from reference cell lines with Cy5 (reference channel). The competitive hybridization and scanning procedures are described in the Supplementary data protocol section.
Image processing and data analysis
Both Cy3 and Cy5 fluorescent images of hybridized microarrays were captured using GSI Lumonics 4000 scanner and ScanArray software. Data were recorded as paired 16-bit TIFF images. Raw images were quantitated using QuantArray 3.0 software (Packard Biochip Technologies, Perkin-Elmer Life Sciences Inc., Boston, MA, USA). The adaptive circle segmentation method, followed by local background subtraction (QAData Reduce Excel macro) and global intensity correction factor normalization, was performed using the sum of all Cy5 median spot signals divided by the sum of all Cy3 median spot signals.
Statistical analysis of the data was performed with the GeneSpringt software version 5.1 (Sigenetics Inc., San Carlos, CA, USA). To make expression values independent of spot intensity and location, within each array, a further per gene normalization was applied to prenormalized data by Intensity dependent per chip (LOWESS) normalization. The normalized intensity measurements from each experiment were log transformed (base 2) and the log ratio of experimental vs reference channel was used as the measure of gene expression. Then, the normalized log ratio of the data was ready for further analysis.
A one-way ANOVA Welch t-test for unpaired comparison of the two groups was applied. We set up P-value less than 0.005 in order to compensate the loose stringent without multiple test correction (MTC) to define a set of significantly up-and downregulated genes.
Hierarchical clustering analysis was performed by J-Express Pro (Molmine AS, Bergen, Norway), based on the filtered genes that meet the statistical criteria as mentioned above, using cosine correlation and the average linkage method. Unless otherwise stated, the LocusLink database and its links to Unigene, OMIM, GenBank and Aceview databases, available at the NCBI home page (www.ncbi.nlm.nih.gov), were used to identify all known human gene functions and chromosome locations. Additional information on genes and their products contributing to common biological processes or cell components was obtained from http://www.geneontology.org.
Pairwise comparisons based on the filtered genes were carried out using a regression test by Minitab software (Minitab Inc., PA, USA). Further correlation between the significant correlated pair gene was tested by stepwise regression in Minitab software.
Verification of gene expression using TaqMan quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
To confirm the expression patterns of certain candidate genes, expression of four genes (ANXA7, SOD1, SEMAE and ARHE) was analysed using quantitative real-time RT-PCR (QRT-PCR) in a 96-well format (Applied Biosystems, Foster City, CA, USA). For each gene of interest, single QRT-PCR reactions were performed on 2 mg of randomly chosen angiogenic tumours (n ¼ 12), and nonangiogenic tumours (n ¼ 10) total RNA samples. The housekeeping gene b-actin was chosen as an endogenous control to normalize the expression data for each gene. All PCR primers and TaqMan probes were designed and purchased from Applied Biosystems according to the company's assays-on-demand protocol (Foster City, CA, USA). Their context sequence lists can be viewed in Supplementary data Table 6 . Probes were labelled with the reporter dye FAM in the 5 0 end and the quencher dye TAMRA in the 3 0 end. Two-step QRT-PCR was performed. Firstly, cDNAs were synthesized from 2 mg total RNA by using a RETROscript first-strand synthesis kit (Ambion Inc., Austin, TX, USA). Secondly, TaqMan quantitative PCR reactions were carried out in 20 ml volumes containing 5 ml of the first cDNA synthesis mix, 1 Â PCR master mix, 10 pmol of each forward and reverse primer and 5 pmol of fluorescent labelled probe. Reactions in 96-well formats were performed in the Applied Biosystems ABI Prism 7500.
Sequence detection system PCR started with an initial step of 10 min at 951C, followed by 40 cycles of 15 s at 951C and 1 min at 601C. In nontemplate control replicates of each gene, no false positive was detected and all the assays were performed in triplicate.
Mitotic count
We counted mitoses from haematoxylin and eosin-stained sections from 16 nonangiogenic and 20 angiogenic lung carcinomas. Briefly, for each case, one high-power field ( Â 400) was randomly chosen and all the cells present were counted. Then all the mitoses present in the field were counted. If there were less than 500 cells in the field, a second field was selected to reach a minimum of 500 total cells. Unpaired t-test (StatView 5.0.1) was used to analyse the results.
Immunohistochemistry test
We have performed immunostaining for the protein encoded by Thrombospondin 1 gene, with higher levels of transcription in angiogenic tumours, and SOD 1 gene, with higher levels of transcription in nonangiogenic tumours. Staining was performed using the anti-SOD1 (Clone 30F11, Novocastra) and the anti-Thrombospondin 1 (Clone8A6B-TSP-1 Novocastra) anti-human mouse monoclonal antibodies using the Envision HRP kit (DAKO). Immunostaining was performed on three multitissue arrays, one containing nonangiogenic n-SCLC (96 cores from 48 cases) and two containing angiogenic tumours, respectively, lung squamous cell carcinomas (120 cores from 60 cases) and lung adenocarcinomas (72 cores from 36 cases).
For SOD 1, we scored the per cent of neoplastic cells with cytoplasm and the per cent with nuclear staining. We also scored the intensity of cytoplasm and nuclear staining on a semiquantitative scale (weak, moderate and strong positivity).
For Thrombospondin 1, we scored the per cent of neoplastic cells with cytoplasm staining and the per cent of stroma surface with cellular and extracellular staining.
